INTRODUCTION
Renal sodium excretion influences arterial blood pressure (ABP) by affecting blood volume and electrolyte composition. Blood pressure is inversely coupled to sodium excretion through negative-feedback regulation by the renin-angiotensin-aldosterone system (RAAS). Sodium excretion is fine-tuned by the adrenal mineralocorticoid aldosterone, which acts at principal cells in the aldosterone-sensitive distal nephron (ASDN) to promote reabsorption of sodium from urine. Activity of epithelial Na þ channels (ENaC), which are localized to the apical membrane of principal cells, is limiting for this sodium reabsorption. As blood pressure and/or effective circulating volume fall, secretion of aldosterone increases and stimulates ENaC in the ASDN to limit sodium excretion in defense of ABP. Mutations that alter the activity or proper regulation of ENaC by the RAAS have been shown to change ABP by affecting renal sodium excretion. Thus, dysregulation of ENaC is a recognized cause of inheritable forms of blood pressure disorders [1] [2] [3] .
Although RAAS regulation of ENaC is a major determinant of renal sodium excretion, this alone does not fully explain the relation between ASDNdependent sodium excretion, ABP, and sodium balance. This is apparent, for example, in the phenomenon of 'aldosterone-escape' in which sodium excretion remains robust in the face of a positive sodium balance and elevated levels of circulating mineralocorticoid [4, 5] . Moreover, it should be emphasized that although the temporal coupling between changes in ABP and renal sodium excretion is tight, pressure-induced changes in circulating aldosterone are comparatively slow. In addition, ENaC have substantial activity in the ASDN of adrenalectomized animals where mineralocorticoid is completely absent (J.D. Stockand, personal communication). This suggests that although aldosterone is robustly capable of increasing ENaC activity, its absence is less effective at decreasing it.
As posited by Guyton [6] , gain in the relation between changes in ABP and sodium excretion is steep (i.e. infinite) in the presence of a normal functioning kidney. The question then is what decreases the activity of ENaC to facilitate sodium excretion in states with low RAAS activity, such as high ABP and/or high salt intake? Emerging evidence, as discussed here, suggests that a control mechanism intrinsic to the ASDN tightly couples ENaC activity to the flow of urine or to the load of sodium delivered by more proximal segments of the nephron. This control mechanism functions together with the RAAS to precisely tune the activity of ENaC. It is dependent on nucleotide agonists in urine that signal in a paracrine/autocrine manner via luminal purinergic receptors to reduce sodium reabsorption as urine sodium delivery rises, thereby enabling an appropriately graded pressure-natriuresis response. Disruption of intrinsic control in the ASDN decreases sodium excretion and promotes a rise of ABP. Figure 1a contains an illustration of the components of this intrinsic control system.
ENaC IS THE FINAL EFFECTOR OF PURINERGIC SIGNALING IN THE ALDOSTERONE-SENSITIVE DISTAL NEPHRON
Recent electrophysiological studies identified ENaC as final effectors of inhibitory purinergic signaling in the mammalian ASDN [7,8,9 && ,10 && ]. These detailed patch clamp studies were performed on the isolated, split-open, mammalian ASDN and are definitive in the sense that they directly quantify effects of purinergic agonism on the open probability of ENaC in paired, single-channel experiments. As shown by the results re-presented in Fig. 1b-d 
P2Y 2 RECEPTORS SIGNAL INHIBITORY PURINERGIC REGULATION OF ENaC IN THE ALDOSTERONE-SENSITIVE DISTAL NEPHRON
Purinergic agonists target two types of receptors: ionotropic P2X and metabotropic P2Y [12] . The former are ligand-gated, nonselective cation channels, whereas the latter are seven transmembranespanning G-protein-coupled receptors (GPCRs) linked by Ga q/11 to phopholipase C (PLC). Receptor subtype-specific agonists and antagonists in patch clamp experiments assaying the activity of ENaC identified apical P2Y 2 receptors as responsible for most of the inhibitory purinergic regulation in the isolated, split-open ASDN [8] . Perhaps the most definitive proof for the importance of P2Y 2 receptors in mediating inhibitory control is the finding that gene deletion of this receptor abolishes ATP regulation of ENaC [8,9 && ].
SIGNALING PATHWAY COUPLING P2Y 2 RECEPTORS TO ENaC
It follows logically from the findings described above that cellular transduction pathways in the ASDN coupling the P2Y 2 receptor to ENaC include signaling through Ga q/11 to PLC. Effects of PLC inhibitors on ATP-dependent regulation of ENaC in the ASDN are consistent with this [7, 8] . In addition, receptor-independent activation of PLC mimics the inhibitory effects on ENaC of ATPinduced activation of P2Y 2 receptors. Moreover,
KEY POINTS
The ASDN contains an intrinsic control system that allows renal sodium excretion to be matched to systemic sodium balance to maintain ABP within a normal range.
Intrinsic control is mediated by paracrine signaling via P2Y 2 receptors on principal cells.
ENaC are the final effectors of inhibitory purinergic signaling in the ASDN.
Loss of intrinsic control decreases sodium excretion and increases ABP.
Renal and ABP phenotypes resulting from dysfunction of intrinsic control are expected to mirror those of aberrant RAAS signaling and ENaC activity.
the reverse is also true: inhibition of PLC mimics the actions of antagonism and knockout of this receptor [8, 13] .
Neither inositol trisphosphate (IP 3 )-dependent calcium signaling nor diacylglycerol-dependent PKC activation, which are expected to occur downstream of PLC stimulation, contribute to ATPdependent regulation of ENaC in the ASDN. Instead, findings point to depletion of apical membrane phosphoinositide 4,5-bisphosphate (PIP 2 ) by PLCmediated hydrolysis [8, 13, 14] . Consistent with this mechanism, membrane PIP 2 is required for normal ENaC activity with its depletion causing decreased open probability [13, 15] .
MOLECULAR DETERMINANTS AND MECHANISMS THAT ENABLE ENaC TO RESPOND TO PURINERGIC SIGNALING
Detailed mutagenesis studies of ENaC identified two regions important for regulation by phosphoinositides. These include cytosolic residues in the extreme amino-terminus and those immediately following the second transmembrane domain [15, 16] . Both regions are rich in conserved basic residues. Deletion or charge neutralization of these basic residues disrupts phosphoinositide regulation of channel activity. The activities of several types of ion channels are dependent on membrane PIP 2 levels [16] [17] [18] . Bonafide PIP 2 -binding sites in these channels are rich in conserved basic residues. This suggested that similar sites in ENaC are also phosphoinositide-binding sites. Supporting this conclusion are findings that ENaC does indeed bind phosphoinositides [19, 20] . Deletion of basic residues in these putative binding sites disrupts phosphoinositide binding. Residues at the amino terminus of ENaC appear particularly important for PIP 2 regulation. The latter is evident in data showing that deletion and neutralization of basic residues in this region not only disrupts PIP 2 regulation but also locks the channel in a normal gating state [15] . Such an observation is consistent with the amino terminus of the channel functioning as a negative regulator of open probability when bound membrane PIP 2 is absent. Accordingly, PIP 2 binding sequesters this negative regulator allowing the channel to gate normally.
INHIBITORY PURINERGIC REGULATION OF ENaC IS TONIC AND INTRINSIC TO THE DISTAL NEPHRON
Recent evidence indicates that purinergic tone in the ASDN is mediated by locally released nucleotides acting in an autocrine/paracrine capacity. By positioning a biosensor in direct contact with the apical membrane of cells in an isolated, perfused ASDN, Sipos et al. [21] demonstrated physiologically important ATP release from intercalated cells in this nephron segment. Inasmuch as these findings indicate that intercalated cells are an important source of nucleotide secretion in the ASDN and that the final effector, ENaC, is localized to principal cells, a paracrine mode of nucleotide action is implicated. The specific modality sensed to trigger inhibitory ATP release, be it flow, pressure, or even urinary sodium concentration, however, has yet to be firmly established.
Additional support for local ATP release from the ASDN comes from using the activity of ENaC as a reporter for purinergic signaling. The broad-spectrum purinergic receptor inhibitor suramin and an enzyme capable of consuming endogenous ATP, hexokinase, both rapidly increase the activity of ENaC in isolated, split-open ASDN naive to exogenous purinergic stimulation [8,9 && ,10 && ]. The results re-presented in Fig. 2 show the effects of hexokinase on ENaC [8] . This tone is absent in P2Y 2 receptor knockout mice as demonstrated by ENaC having a higher basal activity in ASDN isolated from these mice and by the lack of response to suramin/hexokinase. Such findings demonstrate that the ASDN in isolation contains all the components of a local purinergic control system governing sodium reabsorption, and that this system has tone. Further support of this conclusion comes from the evidence that ATP release and urinary ATP levels are significantly lower and ENaC activity is higher in connexin 30 (Cx30) knockout mice compared to wildtype controls [21,22 && ]. In the nephron, Cx30 is expressed only in the apical membranes of intercalated cells, and Cx30 hemichannels function as conduits for nucleotide secretion in the ASDN [21, 23, 24] .
Investigation of the relation between BK Ca channels and ATP release in the ASDN provides additional support for the importance of intercalated cells as a source of urinary ATP [25 & ]. BK Ca channels are localized principally to the apical membrane of intercalated cells in the ASDN. BK Ca channels respond to mechanical stimulation, such as shear-stress resulting from changes in flow, and are known to mediate flow-dependent K þ secretion in the ASDN [26] [27] [28] . SiRNA knockdown of a functionally important subunit of the BK Ca channel, the BK-b4 subunit, decreases ATP release and K þ secretion in immortalized intercalated cells held in culture [25 & ]. The connexin inhibitor, carbenoxolone, has a similar effect on ATP release in these cultured cells. Moreover, BK-b4 knockout mice with high rates of distal urine flow have significantly less ATP in their urine compared to wild-type animals under identical conditions. The activity of ENaC in isolated, split-open ASDN from these knockout animals is also elevated, consistent with decreased tonic regulation by inhibitory purinergic signaling (J.D. Stockand, personal communication). Such findings suggest coupled electrochemical efflux between K þ and ATP as part of the mechanism for shear-stress-induced ATP release in intercalated cells. 
CHANGES IN URINARY NUCLEOTIDE LEVELS REFLECT ARTERIAL BLOOD PRESSURE/SODIUM BALANCE
Increases in the rate of flow of the perfusate stimulate ATP secretion from intercalated cells in the isolated, perfused ASDN [21] . Moreover, connexin hemichannels, which mediate at least part of this nucleotide secretion, are sensitive to mechanical stimulation [21, 24] . ]. Moreover, Cx30 knockout mice on a high sodium diet excrete less sodium: they have a lower fractional excretion of sodium (Fe Na ) compared to wild-type animals treated in an identical manner [22 && ]. A decrease in Fe Na , by definition, points to impaired tubule function likely reflecting inappropriate sodium retention by the ASDN. Supporting this is the finding that Cx30 knockout animals maintained on a high sodium diet have elevated ABP, that is, salt-sensitive hypertension, which is ameliorated by treatment with amiloride [21] . Amiloride blocks ENaC to increase renal sodium excretion. Cx30 knockout mice also have an impaired pressurenatriuresis response, excreting less sodium and urine volume at high ABP compared to wild-type animals [21] . This impaired pressure-natriuresis response reflects inappropriate sodium retention by the ASDN, providing a mechanism for the observed salt-sensitive increase of ABP.
URINARY NUCLEOTIDE LEVELS LINK THE ACTIVITY OF ENaC IN THE ALDOSTERONE-SENSITIVE DISTAL NEPHRON TO CHANGES IN ARTERIAL BLOOD PRESSURE
As shown by results re-presented in Fig. 3 , the activity of ENaC is inversely related to dietary sodium intake [9 && ,29]. Clearly, this reflects regulation, in part, by RAAS particularly when sodium intake is low and RAAS activity is high. The capacity of ENaC to respond to a change in sodium intake, as reflecting feedback regulation, can be quantified by dividing the activity of channels in the isolated ASDN of animals maintained on a high sodium diet by that of channels from animals maintained on a sodium-free regimen [10 && ,22 && ] (see Fig. 3e ). As this fractional ENaC activity approaches zero, capacity to excrete sodium rises. Conversely, as fractional ENaC activity approaches unity, sodium excretion capacity falls. In a corresponding fashion, ABP is expected to be normal in the first instance and elevated in the latter, particularly in the presence of increased sodium intake.
Activity of ENaC in P2Y 2 receptor knockout mice, as noted above, is elevated compared to wild-type animals, and blockade of P2Y 2 receptors and metabolism of ATP have no effect on the activity of channels in ASDN harvested from knockout mice in contrast to their effects in wild-type controls [8, 9 && ,10 && ] (see also Fig. 3 ). The explanation for this is that ENaC in P2Y 2 receptor knockout animals is incapable of sensing or responding to ATP. Bypassing the receptor by directly stimulating PLC, however, does decrease ENaC activity in P2Y 2 receptor knockout mice [8] . Fractional ENaC activity in the P2Y 2 receptor knockout mouse is elevated compared to that in wild-type mice and is nearing equal to that in wild-type mice where RAAS signaling has been saturated by treatment with 11-desoxycorticosterone acetate (DOCA) [10 && ,22 && ] (see also Fig. 3e ). With respect to ENaC, this demonstrates that loss of purinergic regulation is functionally equivalent to saturated regulation by RAAS. ENaC activity also is elevated in Cx30 mice and does not respond to suramin or hexokinase [22 && ]. This is because the capacity of the ASDN to secrete ATP is compromised in this latter case such that ENaC cannot respond to factors that influence ATP levels or signaling as the nucleotide is simply not present. Fractional ENaC activity in Cx30 knockout animals is also elevated compared to wild-type animals and is similar to that in P2Y 2 receptor knockout animals and wild-type animals treated with DOCA. However, ENaC in both Cx30 and P2Y 2 receptor knockout animals retain some of their ability to respond to changes in dietary sodium and aldosterone, albeit with greater activity across all dietary sodium regimens, particularly with high sodium feeding, compared to wild-type animals [9 && ,10 && ,22 && ]. A major effect of aldosterone on ENaC in both wild-type and knockout animals is to increase channel number, whereas knockout of P2Y 2 receptor and Cx30 increases only channel open probability [9 && ,10 && ,22 && ]. This difference in final effect likely explains how intrinsic regulation is able to function in parallel with regulation by the RAAS. Within this framework of parallel extrinsic (i.e. RAAS) and intrinsic (i.e. purinergic) regulation, the increased activity and compromised capacity of ENaC to respond to changes in sodium intake (shown as elevated fractional ENaC activity) in knockout animals almost certainly reflects disruption of regulation by ATP signaling. Indeed, the latter is consistent with evidence for increased activity of ENaC in wild-type but not knockout animals during interdiction of purinergic regulation by suramin or hexokinase [9 && ,10 && ,22 && ]. Linking sodium intakedependent ATP secretion in the ASDN to control of ENaC activity is the finding that the fold increase of ENaC activity in response to blockade of purinergic signaling is greater in wild-type animals fed a high sodium diet compared to animals fed a low sodium diet in which there is no observed response [9 && ,10 && ,22 && ] (see Fig. 3c ). Thus, fractional ENaC activity is elevated in knockout animals because they are incapable of responding to changes in urinary nucleotide levels, as the latter reflect ABP/sodium intake. However, ENaC in these knockout animals retain their full capacity to respond to RAAS signaling which also reflects ABP/sodium intake. This is consistent with intrinsic regulation and extrinsic regulation by RAAS operating in parallel, though often asynchronously, to control ENaC function, with stimulation of the former lowering activity and the latter increasing activity to provide a complete continuum of control. Consistent with this, saturating aldosterone levels in Cx30 and P2Y 2 receptor knockout mice markedly increase fractional ENaC activity, pushing it towards unity, indicating the almost complete loss of the ability of ENaC to respond to feedback regulation [10 && ,22
&&
]. As expected, this treatment in knockout mice also compromises ]. This is when sodium excretion is elevated appropriately in the presence of a sodium load despite high levels of aldosterone [4, 5] . Wild-type animals display aldosterone-escape, in part, because ENaC activity cannot be saturated by RAAS signaling alone in the presence of a positive sodium balance [9 && ,10 && ]. Under these conditions, intrinsic control is providing a counterbalance to the inappropriate, considering the context of sodium balance, actions of RAAS on ENaC. This is protective. Knockout of the P2Y 2 receptor or Cx30 compromises this protection [10 && ,22 && ]. In the presence of a saturating level of aldosterone, sodium excretion and ENaC activity are lower and higher, respectively, in knockout mice compared to wildtype animals under a variety of sodium intake regimens. As noted above, fractional ENaC activity approaches 1.0 in knockout mice treated with aldosterone but is only approximately 0.25 in wild-type animals. Moreover, knockout but not wild-type animals treated with aldosterone and consuming a high sodium diet have elevated ABP [9 && ,10 && ,21,22 && ,30]. Thus, intrinsic regulation of ENaC by purinergic signaling is necessary for aldosterone-escape and loss of this regulation disturbs the normal regulation of ABP.
PHYSIOLOGICAL CONSEQUENCES OF PURINERGIC REGULATION OF ENaC
The above discussion begins to reveal the physiological importance of intrinsic control of renal sodium excretion as mediated by paracrine regulation of ENaC in the ASDN. This system enables the distal nephron to respond appropriately to upstream input and to thereby maintain ABP within a normal range by increasing renal sodium and volume excretion. Restating this, intrinsic control functioning in parallel with RAAS enables appropriate compensatory pressure-natriuresis at elevated ABP. An example of how this intrinsic control system impacts systemic regulation of ABP is the recent finding that specific P2Y 2 receptor agonism dosedependently decreases ABP in wild-type but not P2Y 2 receptor knockout mice [31 && ]. In parallel, P2Y 2 receptor agonism dose-dependently increases urinary sodium excretion in wild-type but not knockout animals by increasing Fe Na and fractional excretion of fluid without affecting glomerular filtration rate. Similar to Cx30 knockout mice, P2Y 2 receptor knockout mice have an impaired pressure-natriuresis response [30,31 && ,32] . Again, this provides the mechanism for hypertension in these latter animals, particularly in the presence of a high sodium diet.
PATHOPHYSIOLOGICAL CONSEQUENCES OF DISRUPTING PURINERGIC REGULATION OF ENaC
Knockout mice lacking the P2Y 2 receptor have increased ABP in the presence of low RAAS activity [30] . This increase of ABP is associated with decreased plasma K þ levels and impaired renal sodium excretion. Because potassium secretion counterbalances sodium reabsorption in the mammalian ASDN and because RAAS is normally suppressed in the face of elevated ABP, the findings above indicate that the ASDN is dysfunctional in P2Y 2 knockout mice and that sodium reabsorption is improperly elevated because of inappropriately activated ENaC even in the presence of suppressed RAAS. The renal and ABP phenotype of P2Y 2 receptor knockout mice are consistent with those of transgenic and knock-in mice with hyperactive ENaC [33] [34] [35] and humans with Liddle's syndrome: a form of hypertension resulting from gain-of-function mutations in ENaC [1, 36] . Amiloride also ameliorates the renal and ABP phenotypes in these latter cases. In fact, all of the above represent variations of end-organ resistance to the normal feedback signals that target ENaC to influence ABP. P2Y 2 receptor knockout mice simply represent end-organ resistance to intrinsic regulation as mediated by paracrine actions of ATP.
Renal dysfunction and salt-sensitive hypertension of Cx30 knockout mice similarly represent improper regulation of ENaC by disrupted intrinsic control [21,22 && ]. There are several related forms of inheritable hypertension and hypotension associated with abnormal renal sodium handling in the ASDN, to include apparent mineralocorticoid excess, glucocorticoid remediable aldosteronism, Geller syndrome, and pseudohypoaldosteronism type I [1] [2] [3] . In contrast to P2Y 2 receptor and Cx30 knockout animals, these represent variations of dysfunctional feedback control of ENaC by RAAS signaling or surrogates of this system. This predicts that the pathophysiological consequences of disrupting intrinsic control should mirror, in a general sense, improper regulation by RAAS. Current findings agree with this.
CONCLUSION
Regulation of ENaC in the ASDN by an intrinsic control system that relies on purinergic signaling, as illustrated in Fig. 4 , enables the kidney to match sodium excretion to sodium balance to maintain ABP in a normal range. This intrinsic control system functions in parallel with RAAS. Compromise of intrinsic control, similar to RAAS, affects ABP through dysregulation of renal sodium excretion.
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